Details for New Drug Application (NDA): 084935
NDA 084935 describes DEXEDRINE, which is a drug marketed by Glaxosmithkline and Impax Labs Inc and is included in three NDAs. Additional details are available on the DEXEDRINE profile page.
The generic ingredient in DEXEDRINE is dextroamphetamine sulfate. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
The generic ingredient in DEXEDRINE is dextroamphetamine sulfate. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 084935
| Tradename: | DEXEDRINE |
| Applicant: | Glaxosmithkline |
| Ingredient: | dextroamphetamine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084935
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
